A European biopharma firm partnered with IQVIA to relaunch a product in the U.S. without local infrastructure, relying on an outsourced 52-person field sales team deployed in just 12 weeks. IQVIA provided staffing, training, analytics, and operational support, later expanding the team to 66 reps across multiple products. When COVID-19 hit, IQVIA pivoted the team to remote engagement with new training, communication, and KPIs, maintaining growth despite market decline and turnover. Over four years, the company exceeded sales targets annually, achieving 20% year-over-year growth against a market growing only 0.1%.

Join for free to read